» Articles » PMID: 33674322

The ChAT-acetylcholine Pathway Promotes Group 2 Innate Lymphoid Cell Responses and Anti-helminth Immunity

Overview
Journal Sci Immunol
Date 2021 Mar 6
PMID 33674322
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Group 2 innate lymphoid cells (ILC2s) reside in multiple tissues, including lymphoid organs and barrier surfaces, and secrete type 2 cytokines including interleukin-5 (IL-5), IL-9, and IL-13. These cells participate in multiple physiological processes including allergic inflammation, tissue repair, metabolic homeostasis, and host defense against helminth infections. Recent studies indicate that neurotransmitters and neuropeptides can play an important role in regulating ILC2 responses; however, the mechanisms that underlie these processes in vivo remain incompletely defined. Here, we identify that activated ILC2s up-regulate choline acetyltransferase (ChAT)-the enzyme responsible for the biosynthesis of acetylcholine (ACh)-after infection with the helminth parasite or treatment with alarmins or cytokines including IL-25, IL-33, and thymic stromal lymphopoietin (TSLP). ILC2s also express acetylcholine receptors (AChRs), and ACh administration promotes ILC2 cytokine production and elicits expulsion of helminth infection. In accordance with this, ChAT deficiency in ILC2s leads to defective ILC2 responses and impaired immunity against helminth infection. Together, these results reveal a previously unrecognized role of the ChAT-ACh pathway in promoting type 2 innate immunity to helminth infection.

Citing Articles

Divalent metal ions enhance bone regeneration through modulation of nervous systems and metabolic pathways.

Luo Y, Liu B, Qiu Y, Li L, Yang F, Zhang C Bioact Mater. 2025; 47:432-447.

PMID: 40034410 PMC: 11872643. DOI: 10.1016/j.bioactmat.2025.01.034.


Neurogenic inflammation and itch in barrier tissues.

Liu R, Buttaci D, Sokol C Semin Immunol. 2025; 77:101928.

PMID: 39798211 PMC: 11893243. DOI: 10.1016/j.smim.2024.101928.


Bidirectional regulation of the brain-gut-microbiota axis following traumatic brain injury.

You X, Niu L, Fu J, Ge S, Shi J, Zhang Y Neural Regen Res. 2024; 20(8):2153-2168.

PMID: 39359076 PMC: 11759007. DOI: 10.4103/NRR.NRR-D-24-00088.


Peripheral and central regulation of neuro-immune crosstalk.

Izumi M, Nakanishi Y, Kang S, Kumanogoh A Inflamm Regen. 2024; 44(1):41.

PMID: 39327628 PMC: 11426056. DOI: 10.1186/s41232-024-00352-3.


PAC1 constrains type 2 inflammation through promotion of CGRP signaling in ILC2s.

Jin Y, Liu B, Li Q, Meng X, Tang X, Jin Y J Clin Invest. 2024; 134(21).

PMID: 39287985 PMC: 11527444. DOI: 10.1172/JCI180109.


References
1.
Chu C, Artis D, Chiu I . Neuro-immune Interactions in the Tissues. Immunity. 2020; 52(3):464-474. PMC: 10710744. DOI: 10.1016/j.immuni.2020.02.017. View

2.
Yang T, Xiao T, Sun Q, Wang K . The current agonists and positive allosteric modulators of 7 nAChR for CNS indications in clinical trials. Acta Pharm Sin B. 2017; 7(6):611-622. PMC: 5687317. DOI: 10.1016/j.apsb.2017.09.001. View

3.
Saenz S, Siracusa M, Perrigoue J, Spencer S, Urban Jr J, Tocker J . IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature. 2010; 464(7293):1362-6. PMC: 2861732. DOI: 10.1038/nature08901. View

4.
Diefenbach A, Colonna M, Koyasu S . Development, differentiation, and diversity of innate lymphoid cells. Immunity. 2014; 41(3):354-365. PMC: 4171710. DOI: 10.1016/j.immuni.2014.09.005. View

5.
Molofsky A, Savage A, Locksley R . Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation. Immunity. 2015; 42(6):1005-19. PMC: 4471869. DOI: 10.1016/j.immuni.2015.06.006. View